Selected research
Market Analysis & Forecast
Global DNA Methylation Assay Market Analysis and Forecast 2026-2032
Market perspective
The global DNA Methylation Assay market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for DNA Methylation Assay is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for DNA Methylation Assay is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for DNA Methylation Assay is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for DNA Methylation Assay is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of DNA Methylation Assay include Illumina, Inc, Thermo Fisher Scientific, EpigenTek, GRAIL, New England Biolabs, Zymo Research, Diagenode, Agena Bioscience and EpigenDx, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for DNA Methylation Assay, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of DNA Methylation Assay, also provides the revenue of main regions and countries. Of the upcoming market potential for DNA Methylation Assay, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the DNA Methylation Assay revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DNA Methylation Assay market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for DNA Methylation Assay revenue, projected growth trends, production technology, application and end-user industry.
DNA Methylation Assay Segment by Company
Illumina, Inc
Thermo Fisher Scientific
EpigenTek
GRAIL
New England Biolabs
Zymo Research
Diagenode
Agena Bioscience
EpigenDx
DNA Methylation Assay Segment by Type
Loci-specific Methylation
Global Methylation
DNA Methylation Assay Segment by Application
Biopharmaceutical Companies
Research Institutions
Others
DNA Methylation Assay Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Methylation Assay market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Methylation Assay and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Methylation Assay.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of DNA Methylation Assay in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of DNA Methylation Assay company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA Methylation Assay revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Loci-specific Methylation
- Global Methylation
Applications
- Biopharmaceutical Companies
- Research Institutions
- Others
Companies covered
- Illumina, Inc
- Thermo Fisher Scientific
- EpigenTek
- GRAIL
- New England Biolabs
- Zymo Research
- Diagenode
- Agena Bioscience
- EpigenDx
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 DNA Methylation Assay Market by Type
- 1.2.1 Global DNA Methylation Assay Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Loci-specific Methylation
- 1.2.3 Global Methylation
- 1.3 DNA Methylation Assay Market by Application
- 1.3.1 Global DNA Methylation Assay Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Biopharmaceutical Companies
- 1.3.3 Research Institutions
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 DNA Methylation Assay Market Dynamics
- 2.1 DNA Methylation Assay Industry Trends
- 2.2 DNA Methylation Assay Industry Drivers
- 2.3 DNA Methylation Assay Industry Opportunities and Challenges
- 2.4 DNA Methylation Assay Industry Restraints
3 Global Growth Perspective
- 3.1 Global DNA Methylation Assay Market Perspective (2021-2032)
- 3.2 Global DNA Methylation Assay Growth Trends by Region
- 3.2.1 Global DNA Methylation Assay Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global DNA Methylation Assay Market Size by Region (2021-2026)
- 3.2.3 Global DNA Methylation Assay Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global DNA Methylation Assay Revenue by Players
- 4.1.1 Global DNA Methylation Assay Revenue by Players (2021-2026)
- 4.1.2 Global DNA Methylation Assay Revenue Market Share by Players (2021-2026)
- 4.1.3 Global DNA Methylation Assay Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global DNA Methylation Assay Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global DNA Methylation Assay Key Players Headquarters & Area Served
- 4.4 Global DNA Methylation Assay Players, Product Type & Application
- 4.5 Global DNA Methylation Assay Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global DNA Methylation Assay Market CR5 and HHI
- 4.6.3 2025 DNA Methylation Assay Tier 1, Tier 2, and Tier 3
5 DNA Methylation Assay Market Size by Type
- 5.1 Global DNA Methylation Assay Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global DNA Methylation Assay Revenue by Type (2021-2032)
- 5.3 Global DNA Methylation Assay Revenue Market Share by Type (2021-2032)
6 DNA Methylation Assay Market Size by Application
- 6.1 Global DNA Methylation Assay Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global DNA Methylation Assay Revenue by Application (2021-2032)
- 6.3 Global DNA Methylation Assay Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Illumina, Inc
- 7.1.1 Illumina, Inc Company Information
- 7.1.2 Illumina, Inc Business Overview
- 7.1.3 Illumina, Inc DNA Methylation Assay Revenue and Gross Margin (2021-2026)
- 7.1.4 Illumina, Inc DNA Methylation Assay Product Portfolio
- 7.1.5 Illumina, Inc Recent Developments
- 7.2 Thermo Fisher Scientific
- 7.2.1 Thermo Fisher Scientific Company Information
- 7.2.2 Thermo Fisher Scientific Business Overview
- 7.2.3 Thermo Fisher Scientific DNA Methylation Assay Revenue and Gross Margin (2021-2026)
- 7.2.4 Thermo Fisher Scientific DNA Methylation Assay Product Portfolio
- 7.2.5 Thermo Fisher Scientific Recent Developments
- 7.3 EpigenTek
- 7.3.1 EpigenTek Company Information
- 7.3.2 EpigenTek Business Overview
- 7.3.3 EpigenTek DNA Methylation Assay Revenue and Gross Margin (2021-2026)
- 7.3.4 EpigenTek DNA Methylation Assay Product Portfolio
- 7.3.5 EpigenTek Recent Developments
- 7.4 GRAIL
- 7.4.1 GRAIL Company Information
- 7.4.2 GRAIL Business Overview
- 7.4.3 GRAIL DNA Methylation Assay Revenue and Gross Margin (2021-2026)
- 7.4.4 GRAIL DNA Methylation Assay Product Portfolio
- 7.4.5 GRAIL Recent Developments
- 7.5 New England Biolabs
- 7.5.1 New England Biolabs Company Information
- 7.5.2 New England Biolabs Business Overview
- 7.5.3 New England Biolabs DNA Methylation Assay Revenue and Gross Margin (2021-2026)
- 7.5.4 New England Biolabs DNA Methylation Assay Product Portfolio
- 7.5.5 New England Biolabs Recent Developments
- 7.6 Zymo Research
- 7.6.1 Zymo Research Company Information
- 7.6.2 Zymo Research Business Overview
- 7.6.3 Zymo Research DNA Methylation Assay Revenue and Gross Margin (2021-2026)
- 7.6.4 Zymo Research DNA Methylation Assay Product Portfolio
- 7.6.5 Zymo Research Recent Developments
- 7.7 Diagenode
- 7.7.1 Diagenode Company Information
- 7.7.2 Diagenode Business Overview
- 7.7.3 Diagenode DNA Methylation Assay Revenue and Gross Margin (2021-2026)
- 7.7.4 Diagenode DNA Methylation Assay Product Portfolio
- 7.7.5 Diagenode Recent Developments
- 7.8 Agena Bioscience
- 7.8.1 Agena Bioscience Company Information
- 7.8.2 Agena Bioscience Business Overview
- 7.8.3 Agena Bioscience DNA Methylation Assay Revenue and Gross Margin (2021-2026)
- 7.8.4 Agena Bioscience DNA Methylation Assay Product Portfolio
- 7.8.5 Agena Bioscience Recent Developments
- 7.9 EpigenDx
- 7.9.1 EpigenDx Company Information
- 7.9.2 EpigenDx Business Overview
- 7.9.3 EpigenDx DNA Methylation Assay Revenue and Gross Margin (2021-2026)
- 7.9.4 EpigenDx DNA Methylation Assay Product Portfolio
- 7.9.5 EpigenDx Recent Developments
8 North America
- 8.1 North America DNA Methylation Assay Revenue (2021-2032)
- 8.2 North America DNA Methylation Assay Revenue by Type (2021-2032)
- 8.2.1 North America DNA Methylation Assay Revenue by Type (2021-2026)
- 8.2.2 North America DNA Methylation Assay Revenue by Type (2027-2032)
- 8.3 North America DNA Methylation Assay Revenue Share by Type (2021-2032)
- 8.4 North America DNA Methylation Assay Revenue by Application (2021-2032)
- 8.4.1 North America DNA Methylation Assay Revenue by Application (2021-2026)
- 8.4.2 North America DNA Methylation Assay Revenue by Application (2027-2032)
- 8.5 North America DNA Methylation Assay Revenue Share by Application (2021-2032)
- 8.6 North America DNA Methylation Assay Revenue by Country
- 8.6.1 North America DNA Methylation Assay Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America DNA Methylation Assay Revenue by Country (2021-2026)
- 8.6.3 North America DNA Methylation Assay Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe DNA Methylation Assay Revenue (2021-2032)
- 9.2 Europe DNA Methylation Assay Revenue by Type (2021-2032)
- 9.2.1 Europe DNA Methylation Assay Revenue by Type (2021-2026)
- 9.2.2 Europe DNA Methylation Assay Revenue by Type (2027-2032)
- 9.3 Europe DNA Methylation Assay Revenue Share by Type (2021-2032)
- 9.4 Europe DNA Methylation Assay Revenue by Application (2021-2032)
- 9.4.1 Europe DNA Methylation Assay Revenue by Application (2021-2026)
- 9.4.2 Europe DNA Methylation Assay Revenue by Application (2027-2032)
- 9.5 Europe DNA Methylation Assay Revenue Share by Application (2021-2032)
- 9.6 Europe DNA Methylation Assay Revenue by Country
- 9.6.1 Europe DNA Methylation Assay Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe DNA Methylation Assay Revenue by Country (2021-2026)
- 9.6.3 Europe DNA Methylation Assay Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China DNA Methylation Assay Revenue (2021-2032)
- 10.2 China DNA Methylation Assay Revenue by Type (2021-2032)
- 10.2.1 China DNA Methylation Assay Revenue by Type (2021-2026)
- 10.2.2 China DNA Methylation Assay Revenue by Type (2027-2032)
- 10.3 China DNA Methylation Assay Revenue Share by Type (2021-2032)
- 10.4 China DNA Methylation Assay Revenue by Application (2021-2032)
- 10.4.1 China DNA Methylation Assay Revenue by Application (2021-2026)
- 10.4.2 China DNA Methylation Assay Revenue by Application (2027-2032)
- 10.5 China DNA Methylation Assay Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia DNA Methylation Assay Revenue (2021-2032)
- 11.2 Asia DNA Methylation Assay Revenue by Type (2021-2032)
- 11.2.1 Asia DNA Methylation Assay Revenue by Type (2021-2026)
- 11.2.2 Asia DNA Methylation Assay Revenue by Type (2027-2032)
- 11.3 Asia DNA Methylation Assay Revenue Share by Type (2021-2032)
- 11.4 Asia DNA Methylation Assay Revenue by Application (2021-2032)
- 11.4.1 Asia DNA Methylation Assay Revenue by Application (2021-2026)
- 11.4.2 Asia DNA Methylation Assay Revenue by Application (2027-2032)
- 11.5 Asia DNA Methylation Assay Revenue Share by Application (2021-2032)
- 11.6 Asia DNA Methylation Assay Revenue by Country
- 11.6.1 Asia DNA Methylation Assay Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia DNA Methylation Assay Revenue by Country (2021-2026)
- 11.6.3 Asia DNA Methylation Assay Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA DNA Methylation Assay Revenue (2021-2032)
- 12.2 SAMEA DNA Methylation Assay Revenue by Type (2021-2032)
- 12.2.1 SAMEA DNA Methylation Assay Revenue by Type (2021-2026)
- 12.2.2 SAMEA DNA Methylation Assay Revenue by Type (2027-2032)
- 12.3 SAMEA DNA Methylation Assay Revenue Share by Type (2021-2032)
- 12.4 SAMEA DNA Methylation Assay Revenue by Application (2021-2032)
- 12.4.1 SAMEA DNA Methylation Assay Revenue by Application (2021-2026)
- 12.4.2 SAMEA DNA Methylation Assay Revenue by Application (2027-2032)
- 12.5 SAMEA DNA Methylation Assay Revenue Share by Application (2021-2032)
- 12.6 SAMEA DNA Methylation Assay Revenue by Country
- 12.6.1 SAMEA DNA Methylation Assay Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA DNA Methylation Assay Revenue by Country (2021-2026)
- 12.6.3 SAMEA DNA Methylation Assay Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst